Equity Analyst - Asia Consumer Sector, Investory

Devi Subhakesan

Equity Research experience of over 20 years include working at leading Asset Management and Brokerage/Investment Banking Firms.  

I focus primarily on the Asia consumer sector and analyse emerging trends and evolving consumption behaviours to publish investment insights on segments where women and/or youth drive purchasing decisions.

My approach combines in-depth industry and company research with rigorous valuation analysis to help investors make informed investment decisions.

Equity Analyst - Asia Consumer Sector

H&H (1112 HK): Near Term Gloom Not Bad Enough to Lead to Long Term Doom.

Health & Happiness (1112 HK): Zesty Paws Acqsn. In Pursuit of Growth. At a Price.

Health & Happiness (1112 HK): 2H2020 -Strong Sales Growth in China Calms Daigou Pain. Stock Upside

ASIA CONSUMER: INSIGHTS AND INVESTMENT IDEAS

Investory

Investory is a Singapore-based boutique independent equity research firm founded in January 2017 with a primary focus on consumption themes across Asia-Pacific.

We aim to generate investible ideas based on consumption trends and outlook. We screen our ideas on several parameters - product potential, long-term growth and management commitment being the most critical.  We follow a fundamental analysis approach in our stock selection process and are not restricted by market cap.

We aspire to grow into a leading source of unbiased research, free of conflict of interest, for investors yearning for independent and disciplined analysis. 

We also undertake bespoke research mandates to support our Institutional clients’ investment needs.

Our team comprises of professionals with extensive experience in the Asian equity markets, in areas ranging from research, servicing institutional clients and investment management.

Equity Bottom-Up

Health And Happiness (H&H) / Equity Bottom-Up

<ul>
<li>
<a href="https://www.smartkarma.com/entities/health-and-happiness-h-h-int" target="_blank" data-smartkarma-citation="entities:20582:1" rel="noopener">Health And Happiness (H&amp;H) (1112 HK)</a> 's first half financial performance was bolstered by robust sales growth in its adult, pet nutrition products even as infant formula sales remained weak.</li>
<li>Multiple sector specific headwinds continue to impact sales of Infant formula in Mainland China. It now accounts for less than 50% of H&amp;H's overall sales.</li>
<li>Segment-Wise valuation suggest stock upside even at conservative multiples. With nearly half the revenues and gross margins being contributed by high growth Adult, Pet nutrition segments, this seems appropriate. </li>
</ul>



Health And Happiness (H&amp;H) (1112 HK) 's first half financial performance was bolstered by robust sales growth in its adult, pet nutrition products even as infant formula sales remained weak.
Multiple sector specific headwinds continue to impact sales of Infant formula in Mainland China. It now accounts for less than 50% of H&amp;H's overall sales.
Segment-Wise valuation suggest stock upside even at conservative multiples. With nearly half the revenues and gross margins being contributed by high growth Adult, Pet nutrition segments, this seems appropriate. 


H&H Holdings: Growing Adult, Pet Care Offset Slowing Baby Care. Segment Valuation Suggest Upside